Buprenorphine / Naloxone Treatment of Addictions – Finnegan Neonatal Abstinence Scoring Tool (FNAST) (Nov 2025)

Buprenorphine / Naloxone Treatment of Addictions – LOW-DOSE ASA IN PREGNANCY (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Home Induction Guide (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – AIM The Next Stage of Buprenorphine Care for OUD (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Buprenorphine/Naloxone Treatment Agreement and Consent Form (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – COWS Scale (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – DSM-5 Clinical Diagnostic Criteria for Opioid Use Disorder (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – OOWs Tool (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – SOWS (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Time for Change Form (May 2025)

Buprenorphine/Naloxone Treatment of Addictions -Enhanced Supports – Suboxone Treatment of Addictions (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Benzodiazepine Mgmt. Withdrawal (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Buprenorphine & Opiod Use Disorder (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Case Studies (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Clinical Interpret of DTR (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – CMHA Buprenorphine/Naloxone Microdosing: The Bernese Method (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Discontinuing Buprenorphine Treatment of OUD: What Do We (Not) Know? (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Induction Overview (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Managing OUD in Primary Care – PEER Simplified Guide (Nov 2025)

Buprenorphine/Naloxone Treatment of Addictions – Personalizing The Treatment of SUD (Volkow) (Nov 2025)